Investigating the key membrane protein changes during in vitro erythropoiesis of protein 4.2 (-) cells (mutations Chartres 1 and 2)

Haematologica

Volumn 95, Issue 8, 2010, Pages 1278-1286

  van den Akker, Emile ^a,b   Satchwell, Timothy J ^a   Pellegrin, Stephanie ^a,b   Flatt, Joanna F ^b   Maigre, Michel ^c   Daniels, Geoff ^b   Delaunay, Jean ^d   Bruce, Lesley J ^b   Toye, Ashley M ^a  

^a Queens Building 239   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c Hopital Louis Pasteur   (France)

^d INSERM   (France)

Author keywords

CD44; CD47; Erythrocyte; Erythropoiesis; Hereditary spherocytosis; Protein 4.2

Indexed keywords

ANKYRIN; CD47 ANTIGEN; ERYTHROCYTE BAND 4.2 PROTEIN; HERMES ANTIGEN; RHESUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; ERYTHROBLAST; ERYTHROCYTE; ERYTHROPOIESIS; GENE MUTATION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PROTEIN DEFICIENCY; PROTEIN INTERACTION;

ADULT; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; ANKYRINS; ANTIGENS, CD44; ANTIGENS, CD47; BASE SEQUENCE; BLOOD PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOSKELETAL PROTEINS; CYTOSKELETON; ERYTHROBLASTS; ERYTHROCYTE MEMBRANE; ERYTHROPOIESIS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BINDING; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 77955854293     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.021063     Document Type: Article

References (45)

1. Eber S, Lux SE. Hereditary spherocytosis--defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol. 2004;41(2):118-141.
2. An X, Mohandas N. Disorders of red cell membrane. Br J Haematol. 2008;141(3):367-375.
3. Gallagher PG. Red cell membrane disorders. Hematology Am Soc Hematol Educ Program. 2005:13-18.
4. Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008; 372(9647):1411-1426.
5. Cartron JP. RH blood group system and molecular basis of Rh-deficiency. Baillieres Best Pract Res Clin Haematol. 1999;12(4):655-689.
6. Bruce LJ, Ghosh S, King MJ, Layton DM, Mawby WJ, Stewart GW, et al. Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. Blood. 2002;100(5):1878-1885.
7. Korsgren C, Lawler J, Lambert S, Speicher D, Cohen CM. Complete amino acid sequence and homologies of human erythrocyte membrane protein band 4.2. Proc Natl Acad Sci USA. 1990;87(2):613-617.
8. Toye AM, Ghosh S, Young MT, Jones GK, Sessions RB, Ramauge M, et al. Protein-4.2 association with band 3 (AE1, SLCA4) in Xenopus oocytes: effects of three natural protein-4.2 mutations associated with hemolytic anemia. Blood. 2005;105(10):4088-4095.
9. Satchwell TJ, Shoemark DK, Sessions RB, Toye AM. Protein 4.2: a complex linker. Blood Cells Mol Dis. 2009;42(3):201-210.
10. Korsgren C, Cohen CM. Purification and properties of human erythrocyte band 4.2. Association with the cytoplasmic domain of band 3. J Biol Chem. 1986;261(12):5536-5543.
11. Korsgren C, Cohen CM. Associations of human erythrocyte band 4.2. Binding to ankyrin and to the cytoplasmic domain of band 3. J Biol Chem. 1988;263(21):10212-10218.
12. Rank G, Sutton R, Marshall V, Lundie RJ, Caddy J, Romeo T, et al. Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutant. Blood. 2009;113(14):3352-3362.
13. Wada H, Kanzaki A, Yawata A, Inoue T, Kaku M, Takezono M, et al. Late expression of red cell membrane protein 4.2 in normal human erythroid maturation with seven isoforms of the protein 4.2 gene. Exp Hematol. 1999;27(1):54-62.
14. Rybicki AC, Schwartz RS, Hustedt EJ, Cobb CE. Increased rotational mobility and extractability of band 3 from protein 4.2-deficient erythrocyte membranes: evidence of a role for protein 4.2 in strengthening the band 3-cytoskeleton linkage. Blood. 1996;88(7):2745-2753.
15. Golan DE, Corbett JD, Korsgren C, Thatte HS, Hayette S, Yawata Y, et al. Control of band 3 lateral and rotational mobility by band 4.2 in intact erythrocytes: release of band 3 oligomers rom low-affinity binding sites. Biophys J. 1996;70(3):1534-1542.
16. Rybicki AC, Heath R, Wolf JL, Lubin B, Schwartz RS. Deficiency of protein 4.2 in erythrocytes from a patient with a Coombs negative hemolytic anemia. Evidence for a role of rotein 4.2 in stabilizing ankyrin on the membrane. J Clin Invest. 1988;81(3): 893-901.
17. Bouhassira EE, Schwartz RS, Yawata Y, Ata K, Kanzaki A, Qiu JJ, et al. An alanine- othreonine substitution in protein 4.2 Cdna is associated with a Japanese form of hereditary emolytic anemia (protein 4.2NIPPON). Blood. 1992;79(7):1846-1854.
18. Kanzaki A, Yasunaga M, Okamoto N, Inoue T, Yawata A, Wada H, et al. Band 4.2 Shiga: 317 GC-->TGC in compound heterozygotes with 142 GCT-->ACT results in band 4.2 deficiency and microspherocytosis. Br J Haematol. 1995;91(2):333-340.
19. Takaoka Y, Ideguchi H, Matsuda M, Sakamoto N, Takeuchi T, Fukumaki Y. A novel mutation in the erythrocyte protein 4.2 gene of Japanese patients with hereditary spherocytosis (protein 4.2 Fukuoka). Br J Haematol. 1994;88(3):527-533.
20. Matsuda M, Hatano N, Ideguchi H, Takahira H, Fukumaki Y. A novel mutation causing an berrant splicing in the protein 4.2 gene associated with hereditary spherocytosis (protein 4.2Notame). Hum Mol Genet. 1995;4(7):1187-1191.
21. Hayette S, Morle L, Bozon M, Ghanem A, Risinger M, Korsgren C, et al. A point mutation in he protein 4.2 gene (allele 4.2 Tozeur) associated with hereditary haemolytic anaemia. Br J Haematol. 1995; 9(4):762-760
22. Beauchamp-Nicoud A, Morle L, Lutz HU, Stammler P, Agulles O, Petermann-Khder R, et al. Heavy transfusions and presence of an anti-protein 4.2 antibody in 4.2(-) hereditary spherocytosis (949delG). Haematologica. 2000;85(1):19-24.
23. Su Y, Ding Y, Jiang M, Hu X, Zhang Z. Protein 4.2 Komatsu (D175Y) associated with the lack of interaction with ankyrin in human red blood cells. Blood Cells Mol Dis. 2007;38(3):221-228.
24. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Science. 2000;288(5473):2051-2054.
25. Mouro-Chanteloup I, Delaunay J, Gane P, Nicolas V, Johansen M, Brown EJ, et al. Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47. Blood. 2003;101(1):338-344.
26. Bruce LJ, Beckmann R, Ribeiro ML, Peters LL, Chasis JA, Delaunay J, et al. A band 3- based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood. 2003;101(10):4180-4188.
27. Nunomura W, Takakuwa Y, Tokimitsu R, Krauss SW, Kawashima M, Mohandas N. Regulation of CD44-protein 4.1 interaction by Ca2+ and calmodulin. Implications for modulation of CD44-ankyrin interaction. J Biol Chem. 1997;272(48):30322-30328.
28. Toye AM, Williamson RC, Khanfar M, Bader-Meunier B, Cynober T, Thibault M, et al. Band Courcouronnes (Ser667Phe): a trafficking mutant differentially rescued by wild-type band 3 and glycophorin A. Blood. 2008;111(11):5380-5389.
29. Beckmann R, Toye AM, Smythe JS, Anstee DJ, Tanner MJ. An N-terminal GFP tag does not alter the functional expression to the plasma membrane of red cell and kidney anion exchanger (AE1) in mammalian cells. Mol Membr Biol. 2002;19(3):187-200.
30. Appleford NE, Wilson K, Houston F, Bruce LJ, Morrison A, Bishop M, et al. alpha- Hemoglobin stabilizing protein is not a suitable marker for a screening test for variant Creutzfeldt-Jakob disease. Transfusion. 2008;48(8):1616-1626.
31. Wainwright SD, Tanner MJ, Martin GE, Yendle JE, Holmes C. Monoclonal antibodies to the membrane domain of the human erythrocyte anion transport protein. Localization of the C-terminus of the protein to the cytoplasmic side of the red cell membrane and distribution of the protein in some human tissues. Biochem J. 1989;258(1):211-220.
32. von Lindern M, Parren-van Amelsvoort M, van Dijk T, Deiner E, van den Akker E, van Emst-de Vries S, et al. Protein kinase C alpha controls erythropoietin receptor signaling. J Biol Chem. 2000;275(44):34719-34727.
33. Neuhoff V, Arold N, Taube D, Ehrhardt W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis. 1988; 9(6):255-262.
34. Yi SJ, Liu SC, Derick LH, Murray J, Barker JE, Cho MR, et al. Red cell membranes of ankyrin-deficient nb/nb mice lack band 3 tetramers but contain normal membrane skeletons. Biochemistry. 1997;36(31):9596-9604.
35. van den Akker E, Satchwell TJ, Pellegrin S, Daniels G, Toye AM. The majority of the in vitro erythroid expansion potential resides in CD34- cells, outweighing the contribution of CD34+ cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica. 2010 Apr 7. [Epub ahead of print] DOI:10.3324/haematol.2009.019828.
36. Bakker WJ, Blazquez-Domingo M, Kolbus A, Besooyen J, Steinlein P, Beug H, et al. FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1. J Cell Biol. 2004;164(2):175-184.
37. Hoffmeyer S, Nurnberg P, Ritter H, Fahsold R, Leistner W, Kaufmann D, et al. Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. Am J Hum Genet. 1998;62(2):269-277.
38. Bourguignon LY. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia. 2001; 6(3):287-297.
39. Leberbauer C, Boulme F, Unfried G, Huber J, Beug H, Mullner EW. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood. 2005;105(1):85-94.
40. Southcott MJ, Tanner MJ, Anstee DJ. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood. 1999;93(12):4425-4435.
41. Bony V, Gane P, Bailly P, Cartron JP. Timecourse expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br J Haematol. 1999;107(2):263-274.
42. Chen K, Liu J, Heck S, Chasis JA, An X, Mohandas N. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci USA. 2009;106(41):17413-17418.
43. Hanspal M, Golan DE, Smockova Y, Yi SJ, Cho MR, Liu SC, et al. Temporal synthesis of band 3 oligomers during terminal maturation of mouse erythroblasts. Dimers and tetramers exist in the membrane as preformed stable species. Blood. 1998;92(1):329-338.
44. Lokeshwar VB, Fregien N, Bourguignon LY. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol. 1994;126(4):1099-1109.
45. Ribeiro ML, Alloisio N, Almeida H, Gomes C, Texier P, Lemos C, et al. Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3. Blood. 2000;96(4):1602-1604.